Atoltivimab Antibody
Atoltivimab (REGN3470), also known as maftivimab/odesivimab and marketed as Inmazeb, is the first FDA-approved monoclonal antibody cocktail for treating Zaire ebolavirus infection. It is used in research to study antiviral mechanisms and has demonstrated efficacy in both in vitro neutralization assays and in vivo non-human primate models.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
